Used as a key intermediate in the synthesis of complex peptide-based pharmaceuticals, particularly in the development of protease inhibitors. Its protected functional groups allow selective deprotection and coupling in solid-phase peptide synthesis, making it valuable for constructing constrained cyclic peptides with enhanced metabolic stability and binding affinity. Commonly employed in research settings for designing drug candidates targeting viral infections and oncology pathways.